The effect of m2 peptide targeted nanoliposomes containing crocin on induction of phenotypic change in tumor macrophages to M1 state

Aims: Crocin has immunomodulatory and anticancer effects. In this study, crocin was used to induce the M1 phenotype in mouse tumor macrophages. Main methods: A targeted liposomal formulation with m2 peptide was prepared and characterized to deliver crocin to the M2 macrophages present in the tumor environment. RT-qPCR and IHC were performed for in vitro and in vivo (in C26 colon carcinoma mouse model at a dose of 50 mg/kg) assessment of M1 induction, respectively. Key findings: In vitro results indicated that liposome modified with m2 peptide was non-toxic to macrophages and had an improved uptake by macrophages compared to the non-targeted formulation and induced M1 phenotype through an IL6-independent pathway. M2 peptide- modified liposome showed considerable tumor accumulation and anti-tumor effects and significantly shifted the phenotype of tumor macrophages towards an anti-tumor M1 phenotype. Significance: Probably the remarkable anti-tumor responses observed in this study with m2 peptide-targeted liposomal formulations containing crocin were due to the enhanced delivery of crocin to the tumor macrophage and the subsequent initiation of anti-tumor immune responses.

Automated summary

In this study, crocin was used to induce the M1 phenotype in mouse tumor macrophages. A targeted liposomal formulation with m2 peptide was prepared to deliver crocin to M2 macrophages. The results showed that the M2 peptide-modified liposome had improved uptake by macrophages and induced the M1 phenotype through an IL6-independent pathway, leading to anti-tumor effects. The study suggests the potential of using m2 peptide-targeted liposomal formulations for enhanced delivery of crocin in tumor therapy.